Updated:
Tianfeng Capital
TIANFENG CAPITAL is an investment group focusing on life sciences and medical and health industries. It has made 7 investments. Its latest investment was in...
Tianfeng Capital
TIANFENG CAPITAL is an investment group focusing on life sciences and medical and health industries. It has made 7 investments. Its latest investment was in PulseCare as part of Series A - II on November 06, 2025.
General information
Firm type
Private Equity
Year founded
2013
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What investment stages does Tianfeng Capital target?
Tianfeng Capital structures its mandate for flexibility, covering early-stage seed and start-up venture rounds, expansion and late-stage growth equity, and pre-IPO or buyout transactions. This full-lifecycle approach means the firm can write initial checks at company formation and continue deploying capital into follow-on rounds and control situations, without being constrained to a single stage fund vehicle.
Does Tianfeng Capital focus exclusively on the Chinese domestic market?
Yes — all available public record indicates Tianfeng Capital concentrates on onshore Chinese private equity. Its headquarters are in Beijing and its investment activity is tied to mainland enterprises, without disclosed cross-border offices or international portfolio companies.
How does Tianfeng Capital's single-platform structure differ from other Chinese private equity firms?
Most Chinese private equity managers operate distinct fund families for venture, growth, and buyout strategies, each with separate limited partners and investment committees. Tianfeng Capital's unified platform collapses those silos, allowing the same team to evaluate a pre-revenue seed deal, a growth-stage Series C, and a mature-company control buyout under one governance framework — a structure that removes internal competition for allocation and simplifies multi-round backing of portfolio companies.
Does Tianfeng Capital participate in buyout transactions or only minority growth investing?
The firm's stated strategy includes buyout transactions alongside minority venture and growth stakes. While the relative weighting between control and minority positions is not publicly detailed, the inclusion of buyout within its multi-stage mandate indicates Tianfeng is prepared to acquire controlling equity when opportunities meet its return thresholds.
Are Tianfeng Capital's assets under management publicly disclosed?
No. Tianfeng Capital has not publicly disclosed its assets under management in regulatory filings, press coverage, or its corporate website. Outside estimates are unavailable, and the firm does not participate in industry AUM benchmarking surveys visible to the public.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: